GE HealthCare: Growth target confirmed for 2023

( – GE HealthCare reported on Monday, as part of its first earnings release since its initial public offering (IPO) at the beginning of the month, a turnover up 8% for the fourth quarter.

The health equipment subsidiary of the American industrial conglomerate says it generated revenues of $4.9 billion in the last three months of 2022.

In organic data, growth over the quarter was 13%.

The Chicago group explains that it benefited from the dynamism of its activities in medical imaging, consumables and clinical accessories and ultrasound.

Its acquisitions had a favorable effect of 1% on turnover, while the firmness of the dollar weighed up to 6% on its quarterly sales.

At the income statement level, net profit amounted to 554 million dollars for the quarter, against 564 million a year earlier, for an adjusted operating profit (Ebit) of 844 million dollars, compared with 827 million a year earlier. .

For 2023, GE HealthCare confirms that it is aiming for organic growth of 5% to 7%, a forecast which it matches with an earnings per share (EPS) target of between 3.60 and 3.75 dollars, against 3.38 dollars in 2022.

The stock was expected down 1.5% Monday morning at the opening of the New York Stock Exchange.

Copyright (c) 2023 All rights reserved.

Source link -84